Simon Thomas
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Co-authors
- Martin Pulé (14 shared papers)Brian Philip (5 shared papers)Karin C. M. Straathof (2 shared papers)Evangelia Kokalaki (6 shared papers)Virna Marin (2 shared papers)Teresa Marafioti (1 shared paper)Karl S. Peggs (3 shared papers)David C. Linch (2 shared papers)
- Journals
- Blood (6 papers)Molecular Therapy (3 papers)Nature Medicine (2 papers)Gene Therapy (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
Simon Thomas
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 41
- Oncology 989
- Immunology 178
- Hematology 82
- Neurology 53
- Genetics 15
Countries citing papers authored by Simon Thomas
This map shows the geographic impact of Simon Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Thomas more than expected).
Fields of papers citing papers by Simon Thomas
This network shows the impact of papers produced by Simon Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Thomas. The network helps show where Simon Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 348 | |
| 2 | 2021 | 228 | |
| 3 | 2020 | 162 | |
| 4 | 2017 | 149 | |
| 5 | 2018 | 76 | |
| 6 | 2008 | 62 | |
| 7 | 2016 | 55 | |
| 8 | 2009 | 52 | |
| 9 | 2023 | 30 | |
| 10 | 2023 | 28 | |
| 11 | 2021 | 22 | |
| 12 | 2024 | 21 | |
| 13 | 2024 | 15 | |
| 14 | 2023 | 9 | |
| 15 | 2014 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2014 | 4 |
About Simon Thomas
Simon Thomas is a scholar working on Oncology, Genetics, Immunology, Epidemiology and Hematology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Protein Tyrosine Phosphatases (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), T-cell and B-cell Immunology (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Oncology (989 citations), Immunology (178 citations), Hematology (82 citations), Neurology (53 citations) and Genetics (15 citations). Simon Thomas has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Martin Pulé, Brian Philip, Karin C. M. Straathof, Evangelia Kokalaki, Virna Marin, Teresa Marafioti, Karl S. Peggs, David C. Linch, Ronjon K. Chakraverty and Leila Mekkaoui. Their work appears in journals such as Blood, Molecular Therapy, Nature Medicine, Gene Therapy and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.